Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Malhar Agarwal"'
Autor:
Francesco Franchi, MD, Fabiana Rollini, MD, Victor Kairouz, MD, Jose Rivas Rios, MD, Andrea Rivas, MD, Malhar Agarwal, MD, Maryuri Briceno, MD, Mustafa Wali, MD, Ahmed Nawaz, MD, Gabriel Silva, MD, Zubair Shaikh, MD, Naji Maaliki, MD, Latonya Been, AAS, Jason Piraino, DPM, Andres M. Pineda, MD, Siva Suryadevara, MD, Daniel Soffer, MD, Martin M. Zenni, MD, Lisa K. Jennings, PhD, Theodore A. Bass, MD, Dominick J. Angiolillo, MD, PhD
Publikováno v:
JACC: Basic to Translational Science, Vol 4, Iss 7, Pp 763-775 (2019)
Summary: Vorapaxar reduces thrombotic cardiovascular events at the expense of increased bleeding. However, the differential pharmacodynamic (PD) effects of vorapaxar according to diabetes mellitus (DM) status are unknown. Moreover, although withdrawa
Externí odkaz:
https://doaj.org/article/b7ea15f9ac70419180a5ce0ec8e4c853
Autor:
Francesco Franchi, Fabiana Rollini, Gabriel Faz, Jose Ramon Rivas, Andrea Rivas, Malhar Agarwal, Maryuri Briceno, Mustafa Wali, Ahmed Nawaz, Gabriel Silva, Zubair Shaikh, Naji Maaliki, Kerolos Fahmi, Latonya Been, Andres M. Pineda, Siva Suryadevara, Daniel Soffer, Martin M. Zenni, Usman Baber, Roxana Mehran, Lisa K. Jennings, Theodore A. Bass, Dominick J. Angiolillo
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 9, Iss 8 (2020)
Background Vorapaxar as an adjunct to dual antiplatelet therapy (DAPT) reduces thrombotic events in patients with prior myocardial infarction at the expense of increased bleeding. Withdrawal of aspirin has emerged as a bleeding reduction strategy. Th
Externí odkaz:
https://doaj.org/article/febf58ad375f48bcb33144fe435a90c7
Autor:
Larisa H. Cavallari, Francesco Franchi, Fabiana Rollini, Latonya Been, Andrea Rivas, Malhar Agarwal, D. Max Smith, Kimberly Newsom, Yan Gong, Amanda R. Elsey, Petr Starostik, Julie A. Johnson, Dominick J. Angiolillo
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background The CYP2C19 nonfunctional genotype reduces clopidogrel effectiveness after percutaneous coronary intervention (PCI). Following clinical implementation of CYP2C19 genotyping at University Florida (UF) Health Shands Hospital in 2012
Externí odkaz:
https://doaj.org/article/deb169b13bc447cdb1a59fd2c42c0efc
Autor:
Daniel Soffer, Zubair Shaikh, Jose Rivas, Siva Suryadevara, Theodore A. Bass, Andrea Rivas, Malhar Agarwal, Maryuri Briceno, Fabiana Rollini, Dominick J. Angiolillo, Naji Maailiki, Andres M. Pineda, Mustafa Wali, Latonya Been, Martin M. Zenni, Francesco Franchi, Ahmed Nawaz, Gabriel Silva
Publikováno v:
JACC: Basic to Translational Science
Visual Abstract
Highlights • Our study supports the feasibility of using rapid CYP2C19 genotyping among both patients with stable and acute coronary syndrome undergoing diagnostic coronary angiography, with intent to undergo ad hoc PCI, in rea
Highlights • Our study supports the feasibility of using rapid CYP2C19 genotyping among both patients with stable and acute coronary syndrome undergoing diagnostic coronary angiography, with intent to undergo ad hoc PCI, in rea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972a9d1cc8504cc716f1a68d9d7d2c0d
http://europepmc.org/articles/PMC7251226
http://europepmc.org/articles/PMC7251226
Autor:
Malhar Agarwal, Naji Maaliki, Fabiana Rollini, Theodore A. Bass, Jose Rivas Rios, Siva Suryadevara, Gabriel Silva, Andres M. Pineda, Daniel Soffer, Lisa K. Jennings, Maryuri Briceno, Victor Kairouz, Andrea Rivas, Mustafa Wali, Francesco Franchi, Ahmed Nawaz, Dominick J. Angiolillo, Jason A. Piraino, Zubair Shaikh, Latonya Been, Martin M. Zenni
Publikováno v:
JACC: Basic to Translational Science, Vol 4, Iss 7, Pp 763-775 (2019)
Summary: Vorapaxar reduces thrombotic cardiovascular events at the expense of increased bleeding. However, the differential pharmacodynamic (PD) effects of vorapaxar according to diabetes mellitus (DM) status are unknown. Moreover, although withdrawa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::761721f8088e6e0941192b82cd4d54b2
https://doi.org/10.1016/j.jacbts.2019.07.011
https://doi.org/10.1016/j.jacbts.2019.07.011
Autor:
Malhar Agarwal, Dmitry M. Yaranov, Latonya Been, Jose Rivas Rios, Maryuri Briceno, Victor Kairouz, Siva Suryadevara, Theodore A. Bass, Dominick J. Angiolillo, Fabiana Rollini, Francesco Franchi, Deepa Nagaraju, Daniel Soffer, Mustafa Wali, Megha Kureti, Martin M. Zenni, Emilio Garcia, Jae Youn Moon, Andrea Rivas
Publikováno v:
Thrombosis and Haemostasis. 120:083-093
In patients requiring dual antiplatelet therapy (DAPT) who also have an indication to be treated with oral anticoagulant (OAC) drugs, aspirin withdrawal reduces the risk of bleeding. There is limited data on the pharmacodynamic effects associated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd472a0a4e5edb34c592721c5323dca5
https://doi.org/10.1055/s-0039-1695772
https://doi.org/10.1055/s-0039-1695772
Autor:
Andres M. Pineda, Daniel Soffer, Theodore A. Bass, Maryuri Briceno, Mustafa Wali, Malhar Agarwal, Siva Suryadevara, Latonya Been, Martin M. Zenni, Dominick J. Angiolillo, Zubair Shaikh, Gabriel Silva, Francesco Franchi, Ahmed Nawaz, Ramez Smairat, Andrea Rivas, Fabiana Rollini, Marc Kaufman
Publikováno v:
Circulation. 139:1661-1670
Background: The platelet inhibitory effects induced by oral P2Y 12 receptor antagonists are delayed in patients with ST-segment–elevation myocardial infarction undergoing primary percutaneous coronary intervention (P-PCI). In turn, this leads to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0800ec5c34bcf7ff1cd588d93ba359a
https://doi.org/10.1161/circulationaha.118.038317
https://doi.org/10.1161/circulationaha.118.038317
Autor:
Usman Baber, Gabriel Faz, Siva Suryadevara, Naji Maaliki, Fabiana Rollini, Dominick J. Angiolillo, Kerolos Fahmi, Malhar Agarwal, Maryuri Briceno, Francesco Franchi, Ahmed Nawaz, Lisa K. Jennings, Mustafa Wali, Andres M. Pineda, Andrea Rivas, Roxana Mehran, Martin M. Zenni, Gabriel Silva, Zubair Shaikh, Theodore A. Bass, Latonya Been, Daniel Soffer, Jose Rivas
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Vorapaxar as an adjunct to dual antiplatelet therapy ( DAPT ) reduces thrombotic events in patients with prior myocardial infarction at the expense of increased bleeding. Withdrawal of aspirin has emerged as a bleeding reduction strategy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69bbe45bbd31172461af90f49cd065ea
http://europepmc.org/articles/PMC7428520
http://europepmc.org/articles/PMC7428520
Autor:
Maryuri Briceno, Zubair Shaikh, Siva Suryadevara, Daniel Soffer, Theodore A. Bass, Dominick J. Angiolillo, Jae Youn Moon, Francesco Franchi, Ahmed Nawaz, Megha Kureti, Fabiana Rollini, Martin M. Zenni, Malhar Agarwal, Jose Rivas Rios, Andrea Rivas, Latonya Been, Deepa Nagaraju, Mustafa Wali
Publikováno v:
Circulation. 137:2450-2462
Background: Switching between different classes of P2Y 12 inhibitors, including de-escalation from ticagrelor to clopidogrel, commonly occurs in clinical practice. However, the pharmacodynamic profiles of this strategy have been poorly explored. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34a417703dcb5a82c467d484fef4a292
https://doi.org/10.1161/circulationaha.118.033983
https://doi.org/10.1161/circulationaha.118.033983
Autor:
Martin M. Zenni, Mustafa Wali, Malhar Agarwal, Theodore A. Bass, Andres M. Pineda, Francesco Franchi, Andrea Rivas, Daniel Soffer, Ahmed Nawaz, Jose Rivas, Fabiana Rollini, M Briecno, Dominick J. Angiolillo, Zubair Shaikh, Gabriel Silva
Publikováno v:
European Heart Journal. 40
Background Although clopidogrel is the most widely used P2Y12 inhibitor, loss-of-function (LOF) allelic variants located within the hepatic cytochrome P450 (CYP) 2C19 gene lead to attenuated bioactivation, increased rates of high platelet reactivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11c500a655f3c1df32e7af6ec8404259
https://doi.org/10.1093/eurheartj/ehz748.0681
https://doi.org/10.1093/eurheartj/ehz748.0681